Search Results for "Multiple Sclerosis Affecting Corpus Collosum"
Original Source: Fatigue and progression of corpus callosum atrophy in multiple sclerosis.
Fatigue is one of the most disabling symptoms in multiple sclerosis (MS) patients. There is no or only weak correlation between conventional magnetic resonance imaging (MRI) parameters and level of fatigue. The aim of this study was to investigate the relationship between progression of corpus callosum (CC) atrophy and fatigue in MS patients. This was a cohort study in 70 patients with relapsing form of MS (RRMS) and serial MRIs over a mean follow-up of 4.8 years [67% female, mean age 42 ± 11 years, me...
Matching Channels
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference i...
ATX-MS-1467 for patients with multiple sclerosis (MS)
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...
Matching News
Ginkgo biloba doesn’t improve cognitive function in multiple sclerosis, research finds
A new study has found that the herbal supplement Ginkgo biloba does not improve cognitive function in patients with multiple sclerosis. Cognitive impairment affects 40-60% of people with MS, most comm...
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2022
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2022 Summary Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord...
Nanoparticle Halts Multiple Sclerosis in mice
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stoppi...
How Does Multiple Sclerosis Progress? Possible Clues Discovered
Researchers have discovered that one or more substances produced by a certain type of immune cell may be involved in the progression of multiple sclerosis (MS), an autoimmune disease affecting the bra...
New nanoparticle halts relapsing remitting multiple sclerosis in mouse model
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stoppi...
Researchers define two categories of multiple sclerosis patients
There are approximately 400,000 people in the United States with multiple sclerosis. Worldwide, the number jumps to more than 2.1 million people. Rather than a one-size-fits-all approach to treating t...
Researchers define 2 categories of multiple sclerosis patients
BOSTON, MA—There are approximately 400,000 people in the United States with multiple sclerosis. Worldwide, the number jumps to more than 2.1 million people. Rather than a one-size-fits-all approach...
Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
In multiple sclerosis, the immune system attacks nerves in the brain and spinal cord, causing movement problems, muscle weakness and loss of vision. Immune cells called dendritic cells, which were pre...
Matching PubMed Articles
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.
Retrovirus-like particles containing the multiple sclerosis-associated retrovirus RNA, significantly found in the cerebrospinal fluid of patients with multiple sclerosis, have been preliminarily assoc...
Multiple sclerosis: Is multiple sclerosis caused by venous insufficiency?
The management of multiple sclerosis in children: a European view.
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the age of 16. A significant proportion of paediatric multiple sclerosis patients develop significant cog...
Background: Multiple sclerosis is a presumed autoimmune disease associated with genetic and environmental risk factors such as infectious mononucleosis. Recent research has shown infectious mononucleo...
